350
Views
27
CrossRef citations to date
0
Altmetric
CASE REPORT

Serum ivermectin levels after enteral and subcutaneous administration for Strongyloides hyperinfection: A case report

, , &
Pages 234-236 | Received 22 Oct 2009, Accepted 23 Oct 2009, Published online: 19 Jan 2010

References

  • Segarra-Newnham M. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Ann Pharmacother 2007;41:1992–2001.
  • Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001;33:1040–7.
  • Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004;17:208–17.
  • Harcourt-Webster JN, Scaravilli F, Darwish AH. Strongyloides stercoralis hyperinfection in an HIV positive patient. J Clin Pathol 1991;44:346–8.
  • Viney ME, Brown M, Omoding NE, Bailey JW, Gardner MP, Roberts E, . Why does HIV infection not lead to disseminated strongyloidiasis? J Infect Dis 2004;190:2175–80.
  • Chiodini PL, Reid AJ, Wiselka MJ, Firmin R, Foweraker J. Parenteral ivermectin in Strongyloides hyperinfection. Lancet 2000;355:43–4.
  • Salluh JI, Feres GA, Velasco E, Holanda GS, Toscano L, Soares M. Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock. Intensive Care Med 2005;31:1292.
  • Turner SA, Maclean JD, Fleckenstein L, Greenaway C. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis. Am J Trop Med Hyg 2005;73:911–4.
  • Marty FM, Lowry CM, Rodriguez M, Milner DA, Pieciak WS, Sinha A, . Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Clin Infect Dis 2005;41:e5–8.
  • Hauber HP, Galle J, Chiodini PL, Rupp J, Birke R, Vollmer E, . Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin. Infection 2005;33:383–6.
  • Pacanowski J, Dos Santos M, Roux A, Le Maignan C, Guillot J, Lavarde V, . Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report. Am J Trop Med Hyg 2005;73:122–4.
  • Gupta S, Jain A, Fanning TV, Couriel DR, Jimenez CA, Eapen GA. An unusual cause of alveolar hemorrhage post hematopoietic stem cell transplantation: a case report. BMC Cancer 2006;6:87.
  • Leung V, Al-Rawahi GN, Grant J, Fleckenstein L, Bowie W. Case report: Failure of subcutaneous ivermectin in treating Strongyloides hyperinfection. Am J Trop Med Hyg 2008;79:853–5.
  • Tarr PE, Miele PS, Peregoy KS, Smith MA, Neva FA, Lucey DR. Rectal administration of ivermectin to a patient with Strongyloides hyperinfection syndrome. Am J Trop Med Hyg 2003;68:453–5.
  • Kitzman D, Wei SY, Fleckenstein L. Liquid chromatographic assay of ivermectin in human plasma for application to clinical pharmacokinetic studies. J Pharm Biomed Anal 2006;40:1013–20.
  • Gann PH, Neva FA, Gam AA. A randomized trial of single-and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 1994;169:1076–9.
  • Igual-Adell R, Oltra-Alcaraz C, Soler-Company E, Sanchez-Sanchez P, Matogo-Oyana J, Rodriguez-Calabuig D. Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis. Expert Opin Pharmacother 2004;5:2615–9.
  • Muennig P, Pallin D, Challah C, Khan K. The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States. Epidemiol Infect 2004;132:1055–63.
  • Concha R, Harrington J, Rogers AI. Intestinal strongyloidiasis: recognition, management, and determinants of outcome. J Clin Gastroenterol 2005;39:203–11.
  • Bannon JP, Fater M, Solit R. Intestinal ileus secondary to Strongyloides stercoralis infection: case report and review of the literature. Am Surg 1995;61:377–80.
  • Nonaka D, Takaki K, Tanaka M, Umeno M, Takeda T, Yoshida M, . Paralytic ileus due to strongyloidiasis: case report and review of the literature. Am J Trop Med Hyg 1998;59:535–8.
  • Klotz U, Ogbuokiri JE, Okonkwo PO. Ivermectin binds avidly to plasma proteins. Eur J Clin Pharmacol 1990;39:607–8.
  • Costa JL, Diazgranados JA. Ivermectin for spasticity in spinal-cord injury. Lancet 1994;343:739.
  • Satou T, Koga M, Koike K, Tada I, Nikaido T. Nematocidal activities of thiabendazole and ivermectin against the larvae of Strongyloides ratti and S. venezuelensis. Vet Parasitol 2001;99:311–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.